3-Nitropropionic Acid Neurotoxicity in Organotypic Striatal and Corticostriatal Slice Cultures Is Dependent on Glucose and Glutamate

Alexi, 1998, 3-Nitropropionic acid's lethal triplet: Cooperative pathways of neurodegeneration, NeuroReport, 9, R57, 10.1097/00001756-199808030-00001

Beal, 1995, Aging, energy and oxidative stress in neurodegenerative diseases, Ann. Neurol., 38, 357, 10.1002/ana.410380304

Beal, 1993, Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid, J. Neurosci., 13, 4181, 10.1523/JNEUROSCI.13-10-04181.1993

Behrens, 1995, 3-Nitropropionic acid induces apoptosis in cultured striatal and cortical neurons, NeuroReport, 6, 545, 10.1097/00001756-199502000-00034

Bradford, 1976, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein–dye binding, Anal. Biochem., 72, 248, 10.1016/0003-2697(76)90527-3

Bogdanov, 1998, Increased vulnerability to 3-nitropropionic acid in an animal model of Huntington's disease, J. Neurochem., 71, 2642, 10.1046/j.1471-4159.1998.71062642.x

Brewer, 1993, Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination, J. Neurosi. Res., 35, 567, 10.1002/jnr.490350513

Brouillet, 1998, Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat, J. Neurochem., 70, 794, 10.1046/j.1471-4159.1998.70020794.x

Brouillet, 1995, Effects of chronic MPTP and 3-nitropropionic acid in nonhuman primates, Curr. Opin. Neurol., 8, 469, 10.1097/00019052-199512000-00014

Browne, 1997, Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal ganglia, Ann. Neurol., 41, 646, 10.1002/ana.410410514

Burke, 1996, Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH, Nature Med., 2, 347, 10.1038/nm0396-347

Deshpande, 1997, 3-Nitropropionic acid increases the intracellular Ca2+ in cultured astrocytes by reverse operation of the Na+–Ca2+ exchanger, Exp. Neurol., 145, 38, 10.1006/exnr.1997.6457

Fellows, 1992, Extracellular brain glucose levels reflect local neuronal activity: A microdialysis study in awake, freely moving rats, J. Neurochem., 59, 2141, 10.1111/j.1471-4159.1992.tb10105.x

Fink, 1996, Energy and glutamate dependency of 3-nitropropionic acid neurotoxicity in culture, Exp. Neurol., 138, 298, 10.1006/exnr.1996.0068

Gähwiler, 1997, Organotypic slice cultures: A technique has come of age, TINS, 20, 471

Green, 1995, Exacerbation of NMDA, AMPA and l-glutamate excitotoxicity by the succinate dehydrogenase inhibitor malonate, J. Neurochem., 64, 2332, 10.1046/j.1471-4159.1995.64052332.x

Green, 1996, Manipulation of membrane potential modulates malonate-induced striatal excitotoxicity in vivo, J. Neurochem., 66, 637, 10.1046/j.1471-4159.1996.66020637.x

Gu, 1996, Mitochondrial defect in Huntington's disease caudate nucleus, Ann. Neurol., 39, 385, 10.1002/ana.410390317

Guyot, 1997, Riluzole protects from motor deficits and striatal degeneration produced by systemic 3-nitropropionic acid intoxication in rats, Neuroscience, 81, 141, 10.1016/S0306-4522(97)00192-9

Hansson, 1999, Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity, Proc. Natl. Acad. Sci. USA, 96, 8727, 10.1073/pnas.96.15.8727

Hassel, 1995, Selective inhibition of the tricarboxylic acid cycle of GABA-ergic neurons with 3-nitropropionic acid in vivo, J. Neurochem., 65, 1184, 10.1046/j.1471-4159.1995.65031184.x

Kristensen, 1999, Excitotoxic effects of non-NMDA receptor agonists in organotypic corticostriatal slice cultures, Brain Res., 841, 143, 10.1016/S0006-8993(99)01833-8

Lowry, 1998, Continuous monitoring of extracellular glucose concentrations in the striatum of freely moving rats with an implanted glucose biosensor, J. Neurochem., 70, 391, 10.1046/j.1471-4159.1998.70010391.x

Maus, 1999, Pyruvate and lactate protect striatal neurons against N-methyl-d-aspartate-induced neurotoxicity, Eur. J. Neurosci., 11, 3215, 10.1046/j.1460-9568.1999.00745.x

McNay, 1999, Extracellular glucose concentrations in the rat hippocampus measured by zero-net-flux: Effects of microdialysis flow rate, strain, and age, J. Neurochem., 72, 785, 10.1046/j.1471-4159.1999.720785.x

Noraberg, 1998, Trimethyltin (TMT) neurotoxicity in organotypic rat hippocampal slice cultures, Brain Res., 738, 305, 10.1016/S0006-8993(97)01358-9

Petersen, 1999, Recent advances on the pathogenesis of Huntington's disease, Exp. Neurol., 157, 1, 10.1006/exnr.1998.7006

Riepe, 1995, Failure of neuronal ion exchange, not potentiated excitation, causes excitotoxicity after inhibition of oxidative phosphorylation, Neuroscience, 64, 91, 10.1016/0306-4522(94)00332-Y

Sanchez-Carbente, 1999, Transient inhibition of glutamate uptake in vivo induces neurodegeneration when energy metabolism is impaired, J. Neurochem., 72, 129, 10.1046/j.1471-4159.1999.0720129.x

Sapp, 1997, Huntingtin localization in brains of normal and Huntington's disease patients, Ann. Neurol., 42, 604, 10.1002/ana.410420411

Schulz, 1995, Involvement of free radicals in excitotoxicity in vivo, J. Neurochem., 64, 2239, 10.1046/j.1471-4159.1995.64052239.x

Schulz, 1995, Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo, J. Neurosci., 15, 8419, 10.1523/JNEUROSCI.15-12-08419.1995

Schulz, 1996, Neuroprotective strategies for treatment of lesions produced by mitochondrial toxins: Implications for neurodegenerative diseases, Neuroscience, 71, 1043, 10.1016/0306-4522(95)00527-7

Stoppini, 1991, A simple method for organotypic cultures of nervous tissue, J. Neurosci. Methods, 37, 173, 10.1016/0165-0270(91)90128-M

Tsacopoulos, 1996, Metabolic coupling between glia an neurons, J. Neurosci., 16, 877, 10.1523/JNEUROSCI.16-03-00877.1996

Zeevalk, 1995, Relative vulnerability of dopamine and GABA neurons in mesencephalic culture to inhibition of succinate dehydrogenase by malonate and 3-nitropropionic acid and protection by NMDA receptor blockade, J. Pharmacol. Exp. Ther., 275, 1124